Blog
The Conference Playbook: How to Maximize Every Investor, Scientific, Medical, and Industry Conference
From investor conferences such as the J.P. Morgan Healthcare Conference, partnering events like the BIO International Convention, scientific congresses such as the American Society of Clinical Oncology (ASCO) Annual Meeting,…
Read MoreLaVoie’s LHS Fifteen-Slide Presentation® for 2026: Make Your Science Stick in the AI Era Returns to BIO 2026
Donna LaVoie and Elise Simard will show biotech leaders how to build investor-ready stories that are clear, memorable, and actionable. Boston, MA, and Fort Lauderdale, FL – June 16, 2026 – LaVoie Strategic Communications…
Read MorePreparing for the IPO Window
What CEOs Need to Get Right in a Selective 2026 Market Executive Brief The life sciences IPO window is open, but selectively. In 2026, readiness is not a financing exercise…
Read MoreScience that SpeaksTM
As Creyon’s scientific platform and organizational momentum expanded, the company sought a digital presence that could clearly communicate its science, strategy, and leadership to a broad set of stakeholders. Creyon’s…
Read MoreRebranding Dyadic: How strategic storytelling helped usher in a new corporate era
In mid-2025, Dyadic International (Nasdaq: DYAI) began a transformation that would reshape both its business model and its public image. The company, with a distinguished 40-year history as a science-driven…
Read MoreAn R&D Day Before the IPO
Turning Science into Story for Investors, Analysts, and Advocates For an emerging biotech company, the period leading up to an IPO is an ideal opportunity to transform years of discoveries…
Read More